Live Breaking News & Updates on Viridian Therapeutics

Stay updated with breaking news from Viridian therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viridian Therapeutics (NASDAQ:VRDN) Trading Down 2.7%

Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) dropped 2.7% during mid-day trading on Wednesday . The company traded as low as $12.97 and last traded at $13.10. Approximately 416,067 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 926,507 shares. The stock had previously closed […] ....

New York , United States , Viridian Therapeutics Company Profile , Viridian Therapeutics Inc , Swiss National Bank , Principal Financial Group Inc , York State Common Retirement Fund , Mirae Asset Global Investments Co , Needham Company , Wolfe Research , Ameritas Investment Partners Inc , Viridian Therapeutics , Get Free Report , Investment Partners , National Bank , Financial Group , Asset Global Investments , New York State Common Retirement Fund , Viridian Therapeutics Daily ,

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management. ....

United States , Goldman Sachs , Viridian Therapeutics Inc , Viridian Therapeutics , Global Healthcare Conference , New York , Annual Global Healthcare Conference , Tuesday June ,

Q2 2024 EPS Estimates for Viridian Therapeutics, Inc. (NASDAQ:VRDN) Raised by B. Riley

Q2 2024 EPS Estimates for Viridian Therapeutics, Inc. (NASDAQ:VRDN) Raised by B. Riley
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Swiss National Bank , Needham Company , Vanguard Group Inc , Ameritas Investment Partners Inc , Mirae Asset Global Investments Co , Viridian Therapeutics Inc , American International Group Inc , Viridian Therapeutics , Free Report , Viridian Therapeutic , Get Free Report , International Group , Investment Partners , National Bank , Mirae Asset Global Investments , Asset Global Investments , Viridian Therapeutics Daily ,

Brokers Issue Forecasts for Viridian Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:VRDN)

Brokers Issue Forecasts for Viridian Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:VRDN)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , Raymond James Associates , Ameritas Investment Partners Inc , Principal Financial Group Inc , Needham Company , Viridian Therapeutics Inc , Viridian Therapeutics Company Profile , Viridian Therapeutics , Free Report , Lifesci Capital , Viridian Therapeutic , Get Free Report , Investment Partners , Kantonalbank Zurich Cantonalbank , State Retirement System , Financial Group , Raymond James , Viridian Therapeutics Daily ,

Lifesci Capital Analysts Increase Earnings Estimates for Viridian Therapeutics, Inc. (NASDAQ:VRDN)

Lifesci Capital Analysts Increase Earnings Estimates for Viridian Therapeutics, Inc. (NASDAQ:VRDN)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Zurcher Kantonalbank Zurich Cantonalbank , Viridian Therapeutics Inc , Stonecrest Wealth Management Inc , Schonfeld Strategic Advisors , Viridian Therapeutics Company Profile , Columbus Asset Advisors , Needham Company , Viridian Therapeutics , Free Report , Lifesci Capital , Viridian Therapeutic , Get Free Report , Forest Capital Management , Strategic Advisors , Crest Wealth Management , Kantonalbank Zurich Cantonalbank , Viridian Therapeutics Daily ,